Jukka Alinikula
PhD, Adjunct professor, Education director of Immudocs
juilal@utu.fi +358 29 450 4577 +358 50 516 7449 Kiinamyllynkatu 10 Turku Työhuone: 7th floor ORCID-tunniste: https://orcid.org/0000-0001-9926-6439 |
Immunology; B cells; somatic hypermutation; antibody genes; immunopharmacology
InFLAMES Flagship; Somatic hypermutation of the genome
I completed my PhD with Prof. Olli Lassila at the University of Turku, focusing on the transcriptional regulation of B cell and plasma cell development and function through loss-of-function studies. During my postdoctoral research at Yale Immunobiology (USA) with David G. Schatz (2012–2015), I investigated the targeting of somatic hypermutation to immunoglobulin genes.
Shortly thereafter, I established my own research group at the Institute of Biomedicine, University of Turku, Finland. In addition to leading independent research projects, I serve as a university lecturer in immunology and drug development.
Protective immunity requires the production of high-affinity antibody-producing cells. My team and I study how high-affinity antibody production is achieved. While most cells minimize somatic mutations to preserve genome stability and prevent tumorigenesis, immunoglobulin genes in B cell development are actively mutated. For example, germinal center B lymphocytes undergo somatic hypermutation (SHM) of immunoglobulin V regions.
Failure to correctly target these mutations can have severe consequences for genome integrity and is implicated in several forms of cancer, particularly leukemia and lymphoma. My research focuses on investigating the molecular mechanisms by which immunoglobulin enhancers recruit SHM to immunoglobulin genes, as well as the processes that lead to the mis-targeting of mutations to other sites in the genome, including several proto-oncogenes.
To address these questions, we utilize techniques such as reporter assays, library screening, genome manipulation, and whole-genome analysis.
Teaching focus ares:
- Immunology
- Immunopharmacology
I teach accrioss various Bachelor's, Master's, MD, and PhD courses in both English and Finnish. My teaching methods include lectures, case-based learning, journal clubs, mentoring, laboratory courses, thesis supervision, and online courses. The topics I cover span innate and adaptive immunity, immunomodulatory drugs and therapeutic antibodies and proteins. I have completed courses on university pedagogy and have supervised and continue to supervise PhD students. Additionally, I participate in follow-up committees of doctoral students.
- Single-cell transcriptome analysis of the early immune response in the lymph nodes of Borrelia burgdorferi-infected mice (2024)
- Microbes and Infection
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity (2024)
- Tumour Virus Research
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences (2022)
- Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma (2022)
- Cancer Research Communications
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation (2019)
- Cell Reports
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting (2019)
- European Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 cells (2018)
- Scandinavian Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells (2017)
- European Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Bcl6 Is Required for Somatic Hypermutation and Gene Conversion in Chicken DT40 Cells (2016)
- PLoS ONE
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - IRF4 Deficiency Leads to Altered BCR Signalling Revealed by Enhanced PI3K Pathway, Decreased SHIP Expression and Defected Cytoskeletal Responses (2015)
- Scandinavian Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Super-Enhancer Transcription Converges on AID (2014)
- Cell
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä) - Targeting of Somatic Hypermutation by immunoglobulin Enhancer and Enhancer-Like Sequences (2014)
- PLoS Biology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - A Critical Context-Dependent Role for E Boxes in the Targeting of Somatic Hypermutation (2013)
- Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation (2011)
- European Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Gene interaction network regulates plasma cell differentiation (2011)
- Scandinavian Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Bursa of Fabricius (2010)
- Encyclopedia of Life Sciences
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP (2010)
- European Journal of Immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Regulation of B Cell Gene Expression and Function by Ikaros, Helios and Bcl6 (2010) Jukka Alinikula
(G5 Artikkeliväitöskirja) - Spontaneous acquisition of plasma cell phenotype in DT40 B cells with inactivation of Bcl-6 (2007)
- Scandinavian Journal of Immunology
(D3 Artikkeli ammatillisessa konferenssijulkaisussa ) - DT40 mutants: a model to study transcriptional regulation of B cell development and function (2006) Alinikula Jukka, Lassila Olli, Nera Kalle-Pekka
(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)